About National Research (NASDAQ:NRCI)
National Research Corporation (NRC) is a provider of analytics and insights that facilitate revenue growth, patient, employee and customer retention and patient engagement for healthcare providers, payers and other healthcare organizations. The Company's portfolio of subscription-based solutions provides information and analysis to healthcare organizations and payers across a range of mission-critical, constituent-related elements, including patient experience and satisfaction, community population health risks, workforce engagement, community perceptions, and physician engagement. The Company's clients range from acute care hospitals and post-acute providers, such as home health, long term care and hospice, to numerous payer organizations. The Company derives its revenue from its annually renewable services, which include performance measurement and improvement services, healthcare analytics and governance education services.
Industry, Sector and Symbol
Industry Business Support Services
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on EquityN/A
Return on AssetsN/A
Frequently Asked Questions for National Research (NASDAQ:NRCI)
What is National Research's stock symbol?
National Research trades on the NASDAQ under the ticker symbol "NRCI."
Where is National Research's stock going? Where will National Research's stock price be in 2017?
1 equities research analysts have issued 1 year target prices for National Research's shares. Their forecasts range from $44.00 to $44.00. On average, they expect National Research's stock price to reach $44.00 in the next year. View Analyst Ratings for National Research.
Who are some of National Research's key competitors?
Some companies that are related to National Research include Ritchie Bros. Auctioneers Incorporated (RBA), WageWorks (WAGE), Aggreko plc (AGK), Lifelock (LOCK), Berendsen PLC (BRSN), The Advisory Board Company (ABCO), Nelnet (NNI), ExlService Holdings (EXLS), Brady Corporation (BRC), Exponent (EXPO), PRA Group (PRAA), H&E Equipment Services (HEES), Serco Group plc (SRP), Equiniti Group PLC (EQN), ICF International (ICFI), TMS International Corp. (TMS), Huron Consulting Group (HURN) and CBIZ (CBZ).
Who are National Research's key executives?
National Research's management team includes the folowing people:
- Steven D. Jackson, President (Age 41)
- Michael D. Hays, Chief Executive Officer, Director (Age 62)
- Kevin R. Karas, Chief Financial Officer, Senior Vice President - Finance, Treasurer, Secretary (Age 59)
- John N. Nunnelly, Lead Independent Director (Age 64)
- Donald M. Berwick M.D., Independent Director (Age 70)
- JoAnn M. Martin, Independent Director (Age 62)
- Barbara J Mowry, Independent Director (Age 69)
How do I buy National Research stock?
Shares of National Research can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is National Research's stock price today?
One share of National Research stock can currently be purchased for approximately $15.57.
How big of a company is National Research?
National Research has a market capitalization of $1.45 billion.
How can I contact National Research?
National Research's mailing address is 1245 Q St, LINCOLN, NE 68508-1430, United States. The company can be reached via phone at +1-402-4752525.
MarketBeat Community Rating for National Research (NRCI)MarketBeat's community ratings are surveys of what our community members think about National Research and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Analysts' Consensus Rating for National Research (NASDAQ:NRCI) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus analyst ratings for company stocks using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||0 Sell Ratings, 1 Hold Rating, 0 Buy Ratings, 0 Strong Buy Ratings|
|Consensus Rating:||Hold (Score: 2.00)|
|Consensus Price Target: ||$44.00 (182.59% upside)|
Consensus Price Target History for National Research (NASDAQ:NRCI)
Analysts' Ratings History for National Research (NASDAQ:NRCI)
(Data available from 11/23/2015 forward)
|Date||Firm||Action||Rating||Price Target||Impact on Share Price||Details|
|2/16/2017||First Analysis||Reiterated Rating||Overweight -> Equal Weight||$45.00 -> $44.00||N/A|
Earnings History and Estimates Chart for National Research (NASDAQ:NRCI)
Earnings History by Quarter for National Research (NASDAQ NRCI)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|11/6/2012||Q312||$0.47||$0.51||$21.52 million||$21.40 million||View||N/A|
Earnings Estimates for National Research (NASDAQ:NRCI)
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History by Quarter for National Research (NASDAQ NRCI)
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Insider Trading History for National Research (NASDAQ NRCI)
No insider trades for this company have been tracked by MarketBeat.com
Latest Headlines for National Research (NASDAQ NRCI)
No headlines for this company have been tracked by MarketBeat.com
Financials are not available for this stock.
National Research (NASDAQ NRCI) Chart for Thursday, November, 23, 2017